The mitotic checkpoint is a targetable vulnerability of carboplatin-resistant triple negative breast...
The mitotic checkpoint is a targetable vulnerability of carboplatin-resistant triple negative breast cancers
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype, lacking effective therapy. Many TNBCs show remarkable response to carboplatin-based chemotherapy, but often develop resistance over time. With increasing use of carboplatin in the clinic, there is a pressing need to identify vulnerabilities of carboplatin-resistant t...
Alternative Titles
Full title
The mitotic checkpoint is a targetable vulnerability of carboplatin-resistant triple negative breast cancers
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_23a5f34fef334ff789f85c69f707a9be
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_23a5f34fef334ff789f85c69f707a9be
Other Identifiers
ISSN
2045-2322
E-ISSN
2045-2322
DOI
10.1038/s41598-021-82780-6
